Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases

被引:133
作者
Marcotte, Douglas J. [1 ]
Liu, Yu-Ting [1 ]
Arduini, Robert M. [1 ]
Hession, Catherine A. [1 ]
Miatkowski, Konrad [1 ]
Wildes, Craig P. [1 ]
Cullen, Patrick F. [1 ]
Hong, Victor [1 ]
Hopkins, Brian T. [1 ]
Mertsching, Elisabeth [2 ]
Jenkins, Tracy J. [1 ]
Romanowski, Michael J. [3 ]
Baker, Darren P. [1 ]
Silvian, Laura F. [1 ]
机构
[1] Biogen Idec Inc, Cambridge Ctr 12, Drug Discovery Dept, Cambridge, MA 02142 USA
[2] Biogen Idec Inc, San Diego, CA 92122 USA
[3] Sunesis Pharmaceut Inc, San Francisco, CA 94080 USA
关键词
Bruton's tyrosine kinase; BTK; Dasatinib; Celera compound; TEC-family; crystal structure; X-LINKED AGAMMAGLOBULINEMIA; CRYSTAL-STRUCTURES; SELECTIVE INHIBITORS; POTENT INHIBITOR; SRC FAMILY; BTK; LFM-A13; DESIGN; DOMAIN; DASATINIB;
D O I
10.1002/pro.321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bruton's tyrosine kinase (BTK), a member of the TEC family of kinases, plays a crucial role in B-cell maturation and mast cell activation. Although the structures of the unphosphorylated mouse BTK kinase domain and the unphosphorylated and phosphorylated kinase domains of human ITK are known, understanding the kinase selectivity profiles of BTK inhibitors has been hampered by the lack of availability of a high resolution, ligand-bound BTK structure. Here, we report the crystal structures of the human BTK kinase domain bound to either Dasatinib (BMS-354825) at 1.9 angstrom resolution or to 4-amino-5-(4-phenoxyphenyl)-7H-pyrrolospyrimidin-7-yl-cyclopentane at 1.6 angstrom resolution. This data provides information relevant to the development of small molecule inhibitors targeting BTK and the TEC family of nonreceptor tyrosine kinases. Analysis of the structural differences between the TEC and Src families of kinases near the Trp-Glu-Ile motif in the N-terminal region of the kinase domain suggests a mechanism of regulation of the TEC family members.
引用
收藏
页码:429 / 439
页数:11
相关论文
共 30 条
[21]   Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases [J].
Rawlings, DJ ;
Scharenberg, AM ;
Park, H ;
Wahl, MI ;
Lin, SQ ;
Kato, RM ;
Fluckiger, AC ;
Witte, ON ;
Kinet, JP .
SCIENCE, 1996, 271 (5250) :822-825
[22]   The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants [J].
Tokarski, John S. ;
Newitt, John A. ;
Chang, Chieh Ying J. ;
Cheng, Janet D. ;
Wittekind, Michael ;
Kiefer, Susan E. ;
Kish, Kevin ;
Lee, Francis Y. F. ;
Borzillerri, Robert ;
Lombardo, Louis J. ;
Xie, Dianlin ;
Zhang, Yaqun ;
Klei, Herbert E. .
CANCER RESEARCH, 2006, 66 (11) :5790-5797
[23]  
TSUKADA S, 1994, ADV EXP MED BIOL, V365, P233
[24]   Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK) [J].
Uckun, Fatih M. ;
Dibirdik, Ilker ;
Qazi, Sanjive ;
Vassilev, Alexel ;
Ma, Hong ;
Mao, Chen ;
Benyumov, Alexey ;
Emami, Katayoon H. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (02) :800-814
[25]   An approach to multi-copy search in molecular replacement [J].
Vagin, A ;
Teplyakov, A .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2000, 56 :1622-1624
[26]   BDTKbase:: The mutation database for X-linked agammaglobullinemia [J].
Valiaho, Jouni ;
Smith, C. I. Edvard ;
Vihinen, Mauno .
HUMAN MUTATION, 2006, 27 (12) :1209-1217
[27]  
van den Akker E, 2004, BIOL CHEM, V385, P409
[28]   THE GENE INVOLVED IN X-LINKED AGAMMAGLOBULINEMIA IS A MEMBER OF THE SRC FAMILY OF PROTEIN-TYROSINE KINASES [J].
VETRIE, D ;
VORECHOVSKY, I ;
SIDERAS, P ;
HOLLAND, J ;
DAVIES, A ;
FLINTER, F ;
HAMMARSTROM, L ;
KINNON, C ;
LEVINSKY, R ;
BOBROW, M ;
SMITH, CIE ;
BENTLEY, DR .
NATURE, 1993, 361 (6409) :226-233
[29]   Crystal Structures of the Lyn Protein Tyrosine Kinase Domain in Its Apo- and Inhibitor-bound State [J].
Williams, Neal K. ;
Lucet, Isabelle S. ;
Klinken, S. Peter ;
Ingley, Evan ;
Rossjohn, Jamie .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (01) :284-291
[30]   Crystal structures of c-Src reveal features of its autoinhibitory mechanism [J].
Xu, WQ ;
Doshi, A ;
Lei, M ;
Eck, MJ ;
Harrison, SC .
MOLECULAR CELL, 1999, 3 (05) :629-638